PDS Biotechnology Corporation
CATIONIC LIPID VACCINE COMPOSITIONS AND METHODS OF USE
Last updated:
Abstract:
The present disclosure provides vaccine compositions comprising at least one adjuvant and at least one therapeutic factor. The disclosure also provides methods of reducing an immune suppressor cell population in a mammal, methods of augmenting an immune response in a mammal, and methods of treating diseases in a mammal utilizing the vaccine compositions.
Status:
Application
Type:
Utility
Filling date:
22 Jul 2021
Issue date:
11 Nov 2021